Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indrajit Das

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Discovery|December 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1Juming Yan, Stacey Allen, Elizabeth McDonald, et al.
Gut|July 10, 2012
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicityIulia Oancea, Chin Wen Png, Indrajit Das, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Immunity|October 19, 2017
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer ImmunotherapyNicole Glodde, Tobias Bald, Debby van den Boorn-Konijnenberg, et al.
Immunity|October 14, 2020
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8<sup>+</sup> T Cell Anti-tumor Functions and Limits the Efficacy of Cancer ImmunotherapyMarianne Weulersse, Assia Asrir, Andrea C Pichler, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8<sup>+</sup> T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
Nature Immunology|August 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammationSusanna S Ng, Fabian De Labastida Rivera, Juming Yan, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Discovery|December 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1Juming Yan, Stacey Allen, Elizabeth McDonald, et al.
Gut|July 10, 2012
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicityIulia Oancea, Chin Wen Png, Indrajit Das, et al.
The Journal of Clinical Investigation|May 15, 2018
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanismsXian-Yang Li, Indrajit Das, Ailin Lepletier, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Immunity|October 19, 2017
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer ImmunotherapyNicole Glodde, Tobias Bald, Debby van den Boorn-Konijnenberg, et al.
Immunity|October 14, 2020
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8<sup>+</sup> T Cell Anti-tumor Functions and Limits the Efficacy of Cancer ImmunotherapyMarianne Weulersse, Assia Asrir, Andrea C Pichler, et al.
Immunity|October 14, 2020
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8<sup>+</sup> T CellsMatthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, et al.
Nature Immunology|August 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammationSusanna S Ng, Fabian De Labastida Rivera, Juming Yan, et al.
Pageof 5